[1]
Eandi, M. 2010. Equity of access to innovative drugs and sustainability of pharmaceutical expenditure. Farmeconomia. Health economics and therapeutic pathways. 11, 2 (Jun. 2010), 53–54. DOI:https://doi.org/10.7175/fe.v11i2.180.